A Phase III, case series clinical study of the reversal of the anticoagulant effects of dabigatran by intravenous administration of 5.0 g idarucizumab (BI 655075) in patients treated with dabigatran etexilate who have uncontrolled bleeding or require emergency surgery or procedures. RE-VERSE-AD (A study of the RE-VERSal Effects of Idarucizumab on Active Dabigatran) trial – 1321.3,
Role: PI,
Boehringer-Ingelheim Pharmaceuticals,
(01/2016 - 01/2017)
Status: Completed
A phase III multicenter clinical trial of Analatro® [antivenin latrodectus (black widow) equine immune F(ab)2] in patients with systemic latrodectism,
Role: Investigator,
Instituto Bioclon S.A.,
(12/2013 - 12/2014)
Status: Completed
Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of lntravenous Varespladib Followed by Oral Varespladib in Addition to Standard of Care in Subjects Bitten by Venomous Snakes (BRAVIO - Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for snakebite),
Role: PI,
Ophirex, Inc.,
Status: Completed
Characteristics of children with positive cannabinoid test,
Role: Investigator,
LLU Dept. of Emergency Medicine,
(06/2020)
Status: Completed
Mass marijuana poisoning: A case series,
Role: PI,
LLU Dept. of Emergency Medicine,
(01/2019 - 01/2020)
Status: Completed
Predictors of adverse outcomes after MDMA (ecstasy) intoxication in the emergency department: a retrospective review,
Role: Investigator,
LLU Dept. of Emergency Medicine,
(10/2015 - 10/2016)
Status: Completed
Pharmacist- specific ACLS training for pharmacy residents to increase pharmacist involvement with ACLS teams at a university hospital,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(04/2015)
Status: Completed
A retrospective review of the efficacy and safety of different treatment modalities for alcohol withdrawal syndrome in an academic medical center,
Role: Investigator,
LLU School of Pharmacy,
(09/2014 - 09/2015)
Status: Completed
State
Review of Emergency Medicine Patients diagnosed with substance use disorders,
Role: Investigator,
California Department of Healthcare Services,
(06/2021)
Status: Approved